- Messages
- 21
- Location
- Austin, TX
I saw my rheumatologist this morning who said there is a phase 3 clinical trial going on for LDN (assume for Crohn's or another AI condition). He believes it will become an FDA-approved drug and then patented, which then means a potential increase in price. Anyone else know about this? I am having good results three weeks in and would be devastated if I suddenly need insurance approval to make the drug affordable. I pay $65 for 60 1.5 mg tablets from People's RX in Austin. I can't imagine paying hundreds of dollars because I need it for an off-label use and insurance won't approve it.